Clinical Trial Results:
PROSPECTIVE, CONTROLLED, DOUBLE-BLIND, RANDOMIZED MULTICENTRIC STUDY
ON THE EFFICACY AND SAFETY OF A TARGET CONTROLLED PLASMA VOLUME REPLACEMENT THERAPY WITH A HYPER-ONCOTIC BALANCED HES 130/0.42 SOLUTION VS AN ISO-ONCOTIC BALANCED HES 130/0.42 SOLUTION COMPARED TO A BALANCED ELECTROLYTE SOLUTION IN ELECTIVE SURGERY OF THE PANCREATIC HEAD
Summary
|
|
EudraCT number |
2008-004175-22 |
Trial protocol |
DE |
Global completion date |
26 Jul 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Feb 2016
|
First version publication date |
17 Feb 2016
|
Other versions |
|
Summary report(s) |
Study Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.